{"id":28417,"date":"2020-07-14T05:34:16","date_gmt":"2020-07-14T05:34:16","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=28417"},"modified":"2020-07-14T05:34:16","modified_gmt":"2020-07-14T05:34:16","slug":"nmda-receptor-antagonists","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/","title":{"rendered":"NMDA receptor antagonists"},"content":{"rendered":"<p>A class of drugs that inhibit the action of the nmda (n-methyl-d-aspartic acid) receptor. Examples include ketamine and phencyclidine (PCP) (often used illicitly for recreational purposes), memantine (used to treat the symptoms of alzheimer\u2019s disease), and amantadine (used to treat side effects of conventional antipsychotic medications, especially dystonia and akathisia).<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A class of drugs that inhibit the action of the nmda (n-methyl-d-aspartic acid) receptor. Examples include ketamine and phencyclidine (PCP) (often used illicitly for recreational purposes), memantine (used to treat the symptoms of alzheimer\u2019s disease), and amantadine (used to treat side effects of conventional antipsychotic medications, especially dystonia and akathisia). &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-28417","post","type-post","status-publish","format-standard","hentry","category-n"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>NMDA receptor antagonists - Definition of NMDA receptor antagonists<\/title>\n<meta name=\"description\" content=\"A class of drugs that inhibit the action of the nmda (n-methyl-d-aspartic acid) receptor. Examples include ketamine and phencyclidine (PCP) (often used illicitly for recreational purposes), memantine (used to treat the symptoms of alzheimer\u2019s disease), and amantadine (used to treat side effects of conventional antipsychotic medications, especially dystonia and akathisia).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NMDA receptor antagonists - Definition of NMDA receptor antagonists\" \/>\n<meta property=\"og:description\" content=\"A class of drugs that inhibit the action of the nmda (n-methyl-d-aspartic acid) receptor. Examples include ketamine and phencyclidine (PCP) (often used illicitly for recreational purposes), memantine (used to treat the symptoms of alzheimer\u2019s disease), and amantadine (used to treat side effects of conventional antipsychotic medications, especially dystonia and akathisia).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-14T05:34:16+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/\",\"name\":\"NMDA receptor antagonists - Definition of NMDA receptor antagonists\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-14T05:34:16+00:00\",\"dateModified\":\"2020-07-14T05:34:16+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A class of drugs that inhibit the action of the nmda (n-methyl-d-aspartic acid) receptor. Examples include ketamine and phencyclidine (PCP) (often used illicitly for recreational purposes), memantine (used to treat the symptoms of alzheimer\u2019s disease), and amantadine (used to treat side effects of conventional antipsychotic medications, especially dystonia and akathisia).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NMDA receptor antagonists\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NMDA receptor antagonists - Definition of NMDA receptor antagonists","description":"A class of drugs that inhibit the action of the nmda (n-methyl-d-aspartic acid) receptor. Examples include ketamine and phencyclidine (PCP) (often used illicitly for recreational purposes), memantine (used to treat the symptoms of alzheimer\u2019s disease), and amantadine (used to treat side effects of conventional antipsychotic medications, especially dystonia and akathisia).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/","og_locale":"en_US","og_type":"article","og_title":"NMDA receptor antagonists - Definition of NMDA receptor antagonists","og_description":"A class of drugs that inhibit the action of the nmda (n-methyl-d-aspartic acid) receptor. Examples include ketamine and phencyclidine (PCP) (often used illicitly for recreational purposes), memantine (used to treat the symptoms of alzheimer\u2019s disease), and amantadine (used to treat side effects of conventional antipsychotic medications, especially dystonia and akathisia).","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/","og_site_name":"Glossary","article_published_time":"2020-07-14T05:34:16+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/","name":"NMDA receptor antagonists - Definition of NMDA receptor antagonists","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-14T05:34:16+00:00","dateModified":"2020-07-14T05:34:16+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A class of drugs that inhibit the action of the nmda (n-methyl-d-aspartic acid) receptor. Examples include ketamine and phencyclidine (PCP) (often used illicitly for recreational purposes), memantine (used to treat the symptoms of alzheimer\u2019s disease), and amantadine (used to treat side effects of conventional antipsychotic medications, especially dystonia and akathisia).","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/nmda-receptor-antagonists\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"NMDA receptor antagonists"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=28417"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28417\/revisions"}],"predecessor-version":[{"id":28418,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28417\/revisions\/28418"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=28417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=28417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=28417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}